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Galectin (gal)-1, -3, and -9 are members of a family of glycan binding proteins that mediate
complex interactions between decidual, inflammatory and trophoblast cells modulating
several processes during gestation, control of the maternal immune system, and
parturition. Their immunomodulatory role in preterm birth and postnatal expression in
preterm infants is unknown. We performed a single center prospective study of 170
preterm infants with a gestational age below 35 weeks. Peripheral venous blood samples
were collected during the neonatal period and galectin-1, -3, and -9 were determined by
ELISA. We noted a strong decline of circulating gal-1 and -3 levels but not gal-9 from birth
to day 7 of life. There was an inverse correlation of gal-1 and -3 levels at birth with
gestational age. Gal-1 levels were remarkably increased in infants born to amniotic
infection syndrome (AIS), which was also observed for gal-9 levels. Infants who
developed early-onset sepsis had higher levels of gal-3 at day 1 as compared to
unaffected infants. Our observational data imply that galectin-1, -3, and -9 levels are
elevated in preterm infants born in an inflammatory milieu such as AIS or EOS. Future
studies need to address whether galectins mediate inflammation-induced preterm birth
and could therefore be a target for clinical trials.
Keywords: galectin-1, galectin-3, galectin-9, preterm infants, amniotic infectionINTRODUCTION
Preterm birth remains an unresolved health problem, accounting worldwide for an approximate
10% of live births. Preterm infants are predisposed to sepsis due to vulnerable body surfaces,
immature immunity, and a variety of injurious exposures, particularly in the first 4 weeks of life.
This is a continuing challenge to clinicians involved in the care of preterm infants, as sepsis andorg February 2021 | Volume 11 | Article 5991041
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mortality and the development of long-term morbidities (1).
Hence there is an urgent need to identify risk factors and
biomarkers aiming at prevention and early treatment of sepsis.
Galectins, a family of glycan binding proteins, are multifactorial
regulators of pregnancy associated process including cellular
interactions between decidual, inflammatory, and trophoblast
cells during gestation and parturition (2). Based on their
structure, galectins are classified into three different types (3): 1)
prototype [e.g., galectin- 1 (gal-1)], containing one carbohydrate
recognition domain (CRD) per subunit that can dimerize, 2)
chimera-type (gal-3), with a carboxyl-terminal CRD joined to an
amino-terminal peptide allowing pentamer formation, and 3)
tandem-repeat (gal-9), displaying two CRD joined by a
functional linker peptide. Their main functions during gestation
is the control of the maternal immune system, regulation of
placental development, and expansion of the maternal-placental
vasculature (4–6). Although data on galectins and parturition is
relatively scarce, a dysregulation of the glycan binding proteins has
been discussed (2). Gal-1 is the most abundant galectin in the
human decidua at term, however its decidual expression and that of
gal-3 decreased as laboring progressed (7). Maternal gal-9
circulating levels are elevated at the time of parturition but
returning to non-pregnant levels during postpartum (8).
Consistent with this, the chimera lectin, gal-3 is highly expressed
at the decidual and placental compartment and after parturition its
expression dramatically decreased as the implantations sites
resorbed (9, 10). Although galectin interactions during gestation
are well characterized, the potential outcome of these interactions
in the context of preterm birth are poorly defined. For instance, a
transcriptomic and proteomic profiling comparing changes in
choriodecidual tissue from women who suffered from
spontaneous preterm labor and gestational-matched non-
laboring controls has identified gal-1 to be upregulated only
during preterm labor, suggesting a possible association with the
underlying pathology (11). In this context, gal-1 expressed on
decidual cells has been shown to down-regulate the IL-6 induced
by LPS stimulus via NF-kB signal pathway inhibition (12, 13). As
IL-6 is an important cytokine related to PTB, gal-1 may be
important in the regulation of local inflammation during the
course of chorioamnionitis (13). Moreover, gal-3 expression
increased in fetal membranes and in the amniotic epithelium in
patients with chorioamniotic infection (14), thereby regulating the
inflammatory response and/or direct interaction with
the pathogens.
In the context of preterm birth, levels of gal-1 and gal-3 in
cord blood correlated with gestational age, growth restriction
and maternal diabetes (15, 16). Decreased cord blood levels of
gal-3 binding protein were noted in association with
chorioamnionitis (17) or in infants with later development of
chronic lung disease (18). The understanding of the potential
immunomodulatory effects of galectins in preterm infants is
crucial. The present study characterizes the postnatal dynamics
of gal-1, -3, and -9 circulating levels in a well-phenotyped
cohort of preterm infants with particular focus on an
“inflammatory” environment.Frontiers in Immunology | www.frontiersin.org 2MATERIAL AND METHODS
Study Population
We performed a prospective single-center study in the perinatal
unit of the Department of Obstetrics and Gynaecology at the
University of Luebeck, Germany. We enrolled a convenience
sample of 170 preterm infants with a gestational age below 35
weeks. Infants with lethal abnormalities were excluded. This
study was part of our IRoN (Immunoregulation of the Newborn)
study project.
Ethical Approval
Ethical approval was given for all study parts by the University of
Luebeck Ethical Committee (IRON AZ 15-304). Informed
written consent was given by parents (as legal representatives)
on behalf of their infants. All blood samples were obtained within
a medically required blood withdrawal procedure.
Definitions
Data were collected from clinical records of mother and child.
Gestational age was defined as best estimate according to post-
menstrual age (obstetrical dating). Amniotic infection (AIS)
was diagnosed when more than two of the following clinical
signs were noted: maternal fever (temperature > 38.0°C) or fetal
tachycardia, maternal elevation of white blood cell count >10/
nL or c-reactive protein levels (> 20 mg/L) without other focus
of infection, painful uterus, foul-smelling amniotic fluid,
preterm labor, preterm rupture of membranes or early-onset
sepsis of the newborn infant. Reasonable suspicion for AIS was
assumed if only one of the signs was noted. Other reasons for
delivery included preeclampsia, pathological vascular Doppler
or pathological cardiotocography, placental abruption
and others.
Small for gestational age (SGA) was defined as a birth weight
less than 10th percentile according to gender-specific standards
for birth weight by post menstrual age in Germany (19). Sepsis
was diagnosed using the NEO-KISS criteria as clinical sepsis or
blood-culture proven sepsis (20, 21). Early-onset sepsis (EOS)
was defined as sepsis (clinical or blood culture pos.) occurring
within the first 72 h of life. Late-onset sepsis (LOS) was defined as
sepsis (clinical or blood culture pos.) occurring after the first 72 h
of life but before 25 days of life.
Collection of Blood Samples
Peripheral venous blood samples were collected along with
routine laboratory sampling at day 1, 3, 7, and 21 and 28 of
life in tubes containing 16 I.E. heparin/ml. Plasma samples were
obtained after centrifugation (6 min, 3,000 g) and stored at -20°C
until analysis. Maximum storage time before centrifugation
was 24 h.
Galectin-1, -3, and -9 ELISA
Gal-1, -3, or -9 concentrations in plasma samples were
determined by ELISA as described previously (4, 22). Briefly,
Corning® 96-Well High-Binding (Fisher-scientific) were
covered with polyclonal anti human gal-1, or gal-3 or gal-9February 2021 | Volume 11 | Article 599104
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Systems, USA respectively) and washed with washing buffer
(0.5% Tween-20 in PBS). Plates were blocked with 3% BSA in
PBS. Individual wells were incubated with serial dilutions of
gal-1, -3, or -9 or plasma samples (diluted 1/4) for 2 h at RT.
Wells were washed and incubated with biotinylated polyclonal
anti-human gal-1, or gal-3 or gal-9 antibodies (500-P210BT
Petrotech, BAF1154, BAF2045 R&D Systems respectively).
Plates were washed six times and incubated with horseradish
peroxidase (HRP)-conjugated streptavidin (Calbiochem, USA).
After eight additional washes, a colorimetric reaction was
developed with the 3,3,5,5′-tetramethyl benzidine (TMB)
substrate (Pierce Biotechnology, USA). The reaction was
stopped by adding one volume of 4 N H2SO4. Absorbance at
450 nm was recorded. Each reported value is the mean of
duplicate assays.
Statistical Analysis
Mann-Whitney U-test and Kruskal-Wallis-Test were applied for
statistical analysis of differences between two or three non-paired
groups, correlations were tested by the Spearman-Rho test. The
level of significance was defined as p <0.05 in single comparisons
and adjusted with Bonferroni-correction for multivariable
testing. For single comparisons, the postnatal age was assessed
in groups (based on the five time points of sample collection), for
multivariable testing the data was transformed using postnatal
age in days as a continuous variable.
We used multivariable linear regression for assessment of the
combined influence of gestational age and postnatal age
(dependent variable: Galectin level, independent variables:
gestational age, birth weight, and postnatal age).
Generalized estimating equation (GEE) with gaussian error
and autoregressive [AR(1)] correlation matrix was used to
determine the association between the gal levels measured on
different days of life and the interaction effects between the
timepoint of measurement (day of life) and either gestational age,
AIS, or EOS. All variables were time-invariant except for gal
levels and day of life. Statistical analysis was performed using
SPSS_25.0 statistical software (SPSS Inc., Chicago, USA).RESULTS
Clinical Characteristics of Infants
Table 1 and Supplementary Table 1 describe the clinical
characteristics of the cohort (n = 170) with a mean (± SD)
gestational age of 28.7 ± 3.1 weeks (GA) and birth weight of
1121 ± 449 g. The cohort included 62 multiples (36.5%), 93 (54.7%)
male, and 38 (22.4%) SGA (small for gestational age) infants. The
predominant causes of preterm delivery were suspected (41.8%) or
definite (20%) amniotic infection syndrome, pathological vascular
Doppler (25.9%) and preeclampsia/HELLP (9.4%). During the
neonatal period, 35 infants (20.6%) developed clinical or blood
culture positive EOS, whereas 18 infants (10.6%) suffered from
clinical LOS and 27 infants (15.8%) from blood-culture proven
LOS. Four patients died during the first 72 h of life.Frontiers in Immunology | www.frontiersin.org 3Circulating Gal-1 and Gal-3 Levels Decline
After Birth
We analyzed circulating gal-1, -3, and -9 levels during the period
of highest infection vulnerability (between day 1 and 28 of life). As
shown in Table 2, gal-1 and gal-3 levels decreased during the first
seven days of life to a plateau while gal-9 peripheral levels in
preterm infants did not change remarkably (Table 2 and
Supplementary Figure 1). The level of gal-1 and 3 was
significantly higher at day 1 as compared to any other postnatal
day after the first week of life in single comparison. In
multivariable testing for the combined influences of gestational
age (GA), birth weight and postnatal age, gestational and postnatal
age remained significant for gal-1 (GA: B = -6.54, 95% CI: -9.28/-
3.79, p < 0.001; postnatal age: B = -2.22, 95%CI: -2.69/-1.74, p <
0.001) and gal-3 (GA: B = -0.66, 95% CI: -1.06/-0.27, p < 0.001;
postnatal age: B = -0.17, 95%CI: -0.26/-0.09, p < 0.001).
Interestingly, circulating levels of gal-1 were higher than gal-3
and gal-9.
Gal-1 and Gal-3 Levels Inversely Correlate
With Gestational Age at Birth
As outlined in Figures 1A, B, concentrations of gal-1 and gal-3 on
day 1 and day 3 of life inversely correlate with gestational age (Day
1: gal-1: R2 = -0.34, P < 0.001, n = 97; gal-3: R2 = -0.077, P = 0.006,
n = 97; Day 3: gal-1: R2 = -0.33, P = 0.005, n = 22; gal-3: R2 =
-0.077, P = 0.006, n = 22). For birth weight, however, the
correlation was less pronounced (Day 1: gal-1: R2 = -0.21, P <
0.001, n = 97; gal-3: R2 = -0.053, P = 0.023, n = 97; Day 3: gal-1: not
significant; gal-3: R2 = -0.19, P = 0.023, n = 22). A weak correlation
was found between levels of gal-1 and gal-3 on day 21 (gestational
age: gal-1: R2 = -0.14, P < 0.001, n = 86; gal-3: R2 = -0.22, P < 0.001,TABLE 1 | Clinical characteristics of the included preterm infants.
Parameters Frequency (Percentage)
Multiples 62 (36.5%)
Gender (male) 93 (54.7%)
Small for gestational age 38 (22.4%)
Reasons for delivery
Preterm labor/pROM/AIS 98 (57.6%)
Path. vascular Doppler/path. CTG 44 (25.9%)
Preeclampsia/HELLP 16 (9.4%)
Placental abruption 6 (3.5%)
Others 6 (3.5%)
Amniotic infection syndrome (AIS)
No AIS 65 (38.2%)
Reasonable suspicion of AIS 71 (41.8%)
Definite AIS 34 (20.0%)
Early-onset-Sepsis (EOS)
No EOS 135 (79.4%)
Clinical Sepsis 33 (19.4%)
Blood-culture pos. EOS 2 (1.2%)
Late-onset-Sepsis (LOS)
No LOS 121 (71.2%)
Clinical Sepsis 18 (10.6%)
Blood-culture pos. LOS 27 (15.8%)
Death during the first 72h 4 (2.4%)February 2021 | VAIS, amniotic infection syndrome; SGA, small for gestational age; pPROM, preterm
rupture of membranes; CTG, Cardiotocography; HELLP, Hemolysis, elevated liver
enzymes, low-platelets syndrome; AIS, amniotic infection syndrome; EOS, early onset
sepsis; LOS, late onset sepsis.olume 11 | Article 599104
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-0.08, P = 0.007, n = 86).
We found no correlation between gal-9 and gestational age or
birth weight. In addition, SGA, gender, and multiple birth had no
impact on gal-1, -3, or -9 serum concentration in our cohort.
Early Inflammation Is Associated With
Increased Galectin Levels in
Preterm Infants
We hypothesized that perinatal inflammation as present in
definite or suspected AIS or EOS/LOS may influence systemic
gal levels. Using single comparisons, we found higher levels of
galectin 1 and 9 in infants born to mothers with severe AIS
(n = 23) during the first day of life (Figure 2) compared to
infants born to mothers with suspected (n = 37) or without
AIS (n = 37). At day 1 of life, for example, gal-1 levels were
remarkably increased in infants born to severe AIS (Figure
2A; mean ± SD; severe AIS: 128.5 ng/ml ± 61.5, suspected AIS:
89.5 ng/ml ± 69.3, no AIS: 63.5 ± 34.9; P < 0.001), which was
also observed for gal-9 (Figure 2E; severe AIS: 4 ng/ml ± 1.6,
suspected AIS: 3 ng/ml ± 1.9, no AIS: 2.8 ± 1.8; P = 0.011). This












































































































































































































































































































































































































FIGURE 1 | Change in serum gal-1 and gal-3 levels in relation to postnatal
and gestational age. (A, B) Levels of gal-1 (ng/ml) (A) and gal-3 (ng/ml) (B) at
day 1 correlated to gestational age (in weeks, P < 0.05, N = 96) as annalyzed
by Mann-Whiteney U-test, respectively.February 2021 | Volume 11 | Article 599104
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early-onset sepsis (EOS, n = 24) had higher levels of all galectins
at day 1 of life compared to unaffected preterm infants (no EOS,
n = 73); (gal-1 (ng/ml) EOS: 112.9 ± 101.7 versus no EOS: 80.9 ±
65.4; P = 0.018, Figure 2A; gal-3 (ng/ml) EOS: 15.2 ± 12.2 versus
no EOS: 10.1 ± 7.5, P = 0.036, Figure 2C; gal-9 (ng/ml) EOS:
3.8 ± 2.9 versus no EOS: 2.9 ± 2.5; P = 0.049, Figure 2E). At day 7
of life, we found gal-9 to be increased in preterm infants suffering
from early-onset sepsis [gal-9 (ng/ml) EOS: n = 16, 4.3 ± 2.3
versus no EOS: n = 50, 2.9 ± 1.2; P < 0.028].
Galectin levels did not differ remarkably in infants who
developed LOS as compared to unaffected infants.
Correlation Between Gestational Age,
Postnatal Age, and Inflammation
To test the hypothesis that galectins levels at different postnatal
time points are significantly associated with clinical parameters, we
applied the GEE statistical model. AIS (B =4.61, p = 0.003) was
associated with the dynamics of gal-1 levels. Gestational age (gal-1:
B = 0.22, p = 0.015) was not significant associated with the
dynamics of any galectin level after adjustment for multiple testing.Frontiers in Immunology | www.frontiersin.org 5DISCUSSION
To our best knowledge, we herein present the first observational
data of gal-1, -3, and -9 levels in a cohort of preterm infants. We
describe that gal-1 and -9 levels are elevated in infants born in an
inflammatory milieu. Increased levels of all galectins are found to
be associated with early-onset sepsis. Gal-1 and -3 levels are
inversely correlated with gestational age and rapidly decline
during the neonatal period.
The role of galectins during amniotic infection is not yet
understood. At term, healthy laboring women have diminished
decidual gal-1 and gal-3 expression levels as compared with non-
laboring women (7). Our data indicate that increased galectin
levels in preterm deliveries may be involved in the
pathophysiological mechanisms of amniotic infection locally at
the fetomaternal interface (13) but also in the systemic immune
response of the offspring. We hereby hypothesize that galectins
may directly or indirectly interact with pathogens (of early-onset
infection) and thereby regulate immune responses.
Noteworthy, we found an inverse correlation between levels
of gal-1 and gal-3 in the newborn and gestational age at delivery.A B
C D
E F
FIGURE 2 | Peripheral blood gal-1 (A, B), gal-3 (C, D), and gal-9 (E, F) levels in relation to AIS and EOS at day 1 (A, C, E) and 7 (B, D, F) of life AIS was
diagnosed clinically: definite signs were noted: maternal fever or fetal tachycardia, maternal increase in white blood cell count >10/ml or c-reactive protein levels (> 20
mg/L) without other focus of infection, painful uterus, foul-smelling amniotic fluid, and either preterm labor or preterm rupture of membrane. Suspicion of AIS was
diagnosed with one clinical sign. EOS was diagnosed along the NEO-KISS criteria (clinical sepsis or blood-culture proven sepsis). *P < 0.05 and ‡P < 0.025 as
analyzed by Mann-Whitney U-test (EOS) and Kruskal-Wallis (AIS).February 2021 | Volume 11 | Article 599104
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a positive correlation of gal-3 concentrations with gestational age
in neonatal whole cord blood (15), which may be related either to
a different kinetics of galectin regulation in cord versus
peripheral blood or to differences in the experimental design of
both studies, as early onset sepsis cases were excluded from our
previous analyses. In comparison with the increasing number of
studies focusing on the galectin profile in the maternal
circulation, information on the systemic variations of galectin
levels in the fetus/newborn is very scarce to date. Current
evidence indicates that uneventful pregnancy is associated with
a steady increase of maternal circulating levels of the three
galectins investigated in this study from the first to the third
trimester (10, 22, 23), suggesting that the kinetics of galectin
secretion may be subject to regulation by different sets of signals
operating in the maternal and fetal compartment. Thus, one
possibility that requires further investigation is that galectins
function to shape innate immunity until the newborn achieves
full immune competence and that the very same signals that
drive fetal maturation and trigger parturition are also involved in
the regulation of the systemic galectin signature as a mechanism
to prepare the fetus for the challenges of extrauterine life. In
support of this notion is the finding that hormones of the HPA
axis involved in the signaling cascade driving parturition [i.e.,
CRH, urocortins (24), glucocorticoids (25–28), DHEA sulfate
(29)] have been shown to modulate galectin expression in a
variety of pathophysiological settings and cell types including
innate imune mediators. On the other hand, since earlier preterm
births are more frequently associated with infections and
activation of a fetal inflammatory response syndrome (i.e.,
chorioamnioninitis) (30), it is also possible that elevated
galectin levels at earlier gestational ages are due to the
described function of galectins as damage associated molecular
patterns (DAMPs), acting as ‘alarmin-like’ molecules to signal
tissue damage and promote an effector response from immune
cells (31–33). In this context, an interesting observation is that
pregnancies with preterm birth due to infection show
significantly higher levels of CRH, urocortin 2, and CRH-R1 in
comparison with patients with idiopathic preterm birth or
premature rupture of membranes without infection (34),
suggesting that placental expression of stress-related pathways
is activated in infective processes.
Our study further revealed an association between elevated
levels of circulating galectins and AIS/EOS in premature infants,
with gal-9 emerging as a possible biomarker for early onset
neonatal sepsis. Considering that, in contrast to the late onset
form, EOS is exclusively caused by vertical transmission of
bacterial infection in utero or intrapartum (35), our results
point to a specific role played by galectins in modulating the
fetal immune response against intraamniotic infection.
Accordingly, we have previously demonstrated that in vitro
stimulation with an invasive strain of S. agalactiae (a Group B
Streptococcus commonly associated with EOS) induced gal-3
expression in cord blood samples of healthy neonates (15).
The role of gal-3 in inflammation and infection has been
well established, serving mainly a pro-inflammatory function:Frontiers in Immunology | www.frontiersin.org 6gal-3 has been shown to enhance neutrophil adhesion
and macrophage migration, promotes their oxidative burst and
functions as a chemoattractant for monocytes and macrophages
(36–39), acting as an important modulator of innate immunity.
Being the first line of defense, the innate immune system is of
outmost importance for protection against infection in the
perinatal period and thus these features of gal-3 make it a
paramount mediator driving neonatal immunity in both term
and preterm infants. In this regard, it has been shown that
circulating levels of gal-3 are higher in neonates than in the adult,
and that resting neonatal neutrophils exhibit a phenotype of
hyperresponsiveness to gal-3 that is further enhanced in births
by vaginal delivery in comparison to C-sections (40).
Interestingly, cord blood levels of galectin 3 binding protein
(Gal3BP, an immunoregulatory glycoprotein with affinity for gal-
1 and gal-3) at birth are increased in preterm neonates and also
show an inverse correlation with gestational age, whereas
decreased levels of the protein were associated with fetal
infections (i.e., choriamnionitis) (17); which led to the
assumption that circulating Gal3BP may complement and
modify gal-3 activity in the neonate. Further, recent studies
have shown that mice deficient for Lgals3BP display enhanced
LPS-induced proinflammatory cytokine release and increased
sensitivity to LPS-induced endotoxin shock (41). In view of these
findings, we speculate that impaired galectin regulation may
contribute to the increased susceptibility of preterm infants to
infection as opposed to term neonates or adults. However, the
differences in the galectin levels may also be a result of infection
instead of its cause. Approaches aimed at promoting gal-3
expression in neonates might, in future, contribute to novel
therapeutic protocols for management of perinatal infection.
Further studies should be encouraged to elucidate the
functional relevance of our findings and to address whether
galectins mediate inflammation-induced preterm birth and their
potential application as a target for clinical trials.DATA AVAILABILITY STATEMENT
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